2011 annual financial data

Marker Therapeutics, Inc. 2011 Operating margin

Marker Therapeutics, Inc. 2011 operating margin with verified reported values.

Direct answer

Operating margin was Not calculable.

Operating income was -2,636,857 USD and net income was -2,028,941 USD.
Operating cash flow was -1,309,867 USD.

Get free Marker Therapeutics, Inc. email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
Not available
Operating income
-2,636,857 USD
Net income
-2,028,941 USD
Operating cash flow
-1,309,867 USD